Mitoxantrone in the treatment of advanced uterine sarcoma : a phase II trial of the gynecologic oncology group

Twenty-nine evaluable patients with metastatic or recurrent leiomyosarcoma or malignant mixed mesodermal tumors of the uterus were treated with mitoxantrone 12 mg/m2 every 3 weeks. All patients had good performance status and measurable disease. Nineteen had prior chemotherapy but only five had prio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of clinical oncology 1990-02, Vol.13 (1), p.32-34
Hauptverfasser:	MUSS, H. B, BUNDY, B. N, ADCOCK, L, BEECHAM, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Biological and medical sciences Chemotherapy Drug Evaluation Female Humans Leiomyosarcoma - drug therapy Medical sciences Middle Aged Mitoxantrone - therapeutic use Multicenter Studies as Topic Neoplasm Recurrence, Local - drug therapy Neoplasms, Germ Cell and Embryonal - drug therapy Pharmacology. Drug treatments Remission Induction Survival Rate Uterine Neoplasms - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!